William Blair Initiates Coverage of Bruker with Outperform Rating | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – William Blair initiated coverage of Bruker on Wednesday with an Outperform rating and a Core Growth company profile.

Analyst Amanda Murphy estimated 2011 EPS at $.89 on $1.63 billion in revenues, and 2012 EPS at $1.05 on $1.77 billion in revenues.

In a research note, Murphy cited Bruker's spending on R&D, which she said is higher than its peers on a percentage-of-revenue basis, resulting in strong brand reputation and a "robust" IP portfolio.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.